HealthcareStifel starts ORIC at purchase, cites prostate cancer drug candidateBy Helitra.com·September 7, 2024·1 min read Stifel starts ORIC at purchase, cites prostate cancer drug candidate Source: SeekingalphaADVERTISEMENT ADVERTISEMENTbuy cancer candidate cites drug ORIC prostate starts Stifel Post navigation Previous storyCatalyst Watch: Apple's iPhone occasion, Oracle earnings, Google antitrust trial, and the August CPI printNext storyAllurion started at buy by Roth MKM over weight-loss device potential
Fitness · HealthcareScientists Found a Way to Boost Weight Loss Without Sacrificing Muscle, but There’s a CatchNovember 22, 2026Scientists at the University of California, Berkeley, have discovered a potential way to make Ozempic-style weight loss more effective without sacrificing muscle. Instead…
Fitness · HealthcareI’m a testosterone expert. This is the biggest mistake men are making with their healthNovember 22, 2026Our series The Expert View brings you specialist health advice from professionals. In this article, we hear from Professor Tet Yap, a consultant…
Fitness · HealthcareWeights Versus Cardio: Which Exercise Is Actually Better for Your Mental Health?November 22, 2026A major new study suggests lifting weights could do more than build muscle. It may also help reduce symptoms of depression—and researchers found…